Some of the most high-profile names that are likely to headline this year's IPO market resurgence include Swedish payments ...

JPMorgan initiated coverage on WeRide Inc (NASDAQ: WRD), bestowing an Overweight rating on the stock along with a price target of $21.00. Currently trading at $14.50, the $4 billion market cap company ...

When it comes to stock market debuts, 2024 was not an active year for many industries, not least cross-border payments, but ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

After 30 years, an investor who bought in at the IPO, held on, and reinvested all of their dividends, would have seen a $75 ...

IPO stocks are expected to see a bright year ahead this 2025, especially backed by the ongoing bull run at the US stock ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Dr Agarwal's Healthcare IPO price band is set at ₹382 to ₹402 per equity share. The subscription date is from January 29 to January 31.

Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial ...

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

Venture Global is the second-largest exporter of liquefied natural gas, or LNG, in the United States, and one of Trump's ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now ...